CoChat

Approaches to Prevention of Cardiovascular Complications and Events in Diabetes Mellitus

Coccheri, Sergio · 2007 · Drugs

The DOI matches its Crossref record; 259 of the 263 references it cites were found in a registry or an index.

Abstract

Diabetes mellitus affects about 8% of the adult population. The estimated number of patients with diabetes, presently about 170 million people, is expected to increase by 50-70% within the next 25 years. Diabetes is an important component of the complex of 'common' cardiovascular risk factors, and is responsible for acceleration and worsening of atherothrombosis. Major cardiovascular events cause about 80% of the total mortality in diabetic patients. Diabetes also induces peculiar microangiopathic changes leading to diabetic nephropathy conducive to end-stage renal failure, and to diabetic retinopathy that may progress to vision loss and blindness. In terms of major cardiovascular events, coronary heart disease and ischaemic stroke are the main causes of morbidity and mortality in diabetic patients. Peripheral arterial disease frequently occurs, and is more likely to be conducive to critical limb ischaemia and amputation than in the absence of diabetes. Although there are a number of differences in the pathogenesis and clinical features of diabetic macroangiopathy and microangiopathy, these two entities often coexist and induce mutually worsening effects. Endothelial injury, dysfunction and damage are common starting points for both conditions. Causes of endothelial injury can be distinguished into those 'common' to nondiabetic atherothrombosis, such as hypertension, dyslipidaemia, smoking, hypercoagulability and platelet activation; and those more specific and in some cases…

Overview

Integrity signals

Registry

Crossref · 10.2165/00003495-200767070-00005

Cites

259 of 259 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

1 retracted

Show all 259 references

Research works printed but not linked: 18

  1. Rossi, 2005, Heart Int, 1, 18
  2. Mamcarz, 2004, Pol Arch Med Wewn, 112, 1433
  3. Dormandy, 1999, Semin Vasc Surg, 12, 138
  4. Tarchini, 2005, G Ital Nefrol, 22, S15
  5. Sampson, 1990, Q J Med, 75, 635
  6. Sun, 1998, Int J Exp Pathol, 79, 207
  7. Hogikyan, 1998, J Clin Endocrinol Metab, 83, 1946
  8. Ford-Hutchinson, 1985, Fed Proc, 44, 25
  9. Ostermann, 1986, Heamostasis, 16, 386
  10. Lecrubier, 1980, Haemostasis, 9, 43
  11. Juhan-Vague, 1991, Diabetologia, 34, 457, 10.1007/bf00403280 · DOI · Paper page
  12. Allemann, 2006, Curr Med Res Opin, 617-, 23
  13. 1989, Diabetes, 38, 491, 10.2337/diab.38.4.491 · doi:10.2337/diab.38.4.491
  14. 2002, Circulation, 106, 288
  15. Lovell, 2001, Cochrane Database Syst Rev, 1, CD002183
  16. Achour, 2005, JNephrol, 18, 568
  17. Richter, 2006, Cochrane Database Syst Rev, 18, CD006060
  18. Keech, 2005, Lancet, 26, 1849

Cited by

See all 155

Metadata

Authors
Coccheri, S.
Affiliations
University of Bologna (IT)
Corresponding author
Coccheri, Sergio
Venue
Drugs
Published
2007
Volume
67
Issue
7
Pages
997-1026
ISSN
0012-6667 (ISSN-L)
OpenAlex
W1986199468
Cited by
139
References
263
Citations by year
2026: 2 · 2025: 4 · 2024: 5 · 2023: 2 · 2022: 5 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 5 · 2017: 3 · 2016: 7 · 2015: 6 · 2014: 5 · 2013: 12 · 2012: 15
FWCI
2.20
Type
journal article
Language
en
Open access
closed
Locations
  • Drugs (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
diabetes mellitus, cardiovascular complications, cardiovascular disease prevention, macroangiopathy, microangiopathy, endothelial dysfunction, atherothrombosis, diabetic nephropathy, diabetic retinopathy, peripheral arterial disease, coronary artery disease, ischemic stroke, advanced glycation end products, RAGE, oxidative stress, nitric oxide, renin-angiotensin-aldosterone system, aspirin, picotamide, clopidogrel, antiplatelet therapy, endothelial inflammation
MeSH terms
Cardiovascular Diseases, Diabetes Mellitus, Fibrinolytic Agents, Humans, Hypoglycemic Agents, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Approaches to Prevention of Cardiovascular Complications and Events in Diabetes Mellitus. https://app.cochat.ai/papers/10.2165/00003495-200767070-00005
The paper
Coccheri, S. (2007). Approaches to Prevention of Cardiovascular Complications and Events in Diabetes Mellitus. Drugs. https://doi.org/10.2165/00003495-200767070-00005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.